{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:48:27Z","timestamp":1792838907571,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T00:00:00Z","timestamp":1443484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s12072-015-9665-6","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T12:26:07Z","timestamp":1443529567000},"page":"124-132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":218,"title":["Albumin in chronic liver disease: structure, functions and therapeutic implications"],"prefix":"10.1007","volume":"10","author":[{"given":"Rosaria","family":"Spinella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Sawhney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Jalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,29]]},"reference":[{"key":"9665_CR1","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.27322","volume":"60","author":"M Domenicali","year":"2014","unstructured":"Domenicali M, Baldassarre M, Giannone FA, Naldi M, Mastroroberto M, Biselli M, Laggetta M, et al. Posttranscriptional changes of serum albumin: clinical and prognostic significance in hospitalized patients with cirrhosis. Hepatology. 2014;60:1851\u20131860.","journal-title":"Hepatology"},{"key":"9665_CR2","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jhep.2013.06.013","volume":"59","author":"K Oettl","year":"2013","unstructured":"Oettl K, Birner-Gruenberger R, Spindelboeck W, Stueger HP, Dorn L, Stadlbauer V, Putz-Bankuti C, et al. Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survival. J Hepatol. 2013;59:978\u2013983.","journal-title":"J Hepatol"},{"key":"9665_CR3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.22913","volume":"50","author":"R Jalan","year":"2009","unstructured":"Jalan R, Schnurr K, Mookerjee RP, Sen S, Cheshire L, Hodges S, Muravsky V, et al. Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality. Hepatology. 2009;50:555\u2013564.","journal-title":"Hepatology"},{"key":"9665_CR4","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jhep.2013.08.001","volume":"59","author":"R Jalan","year":"2013","unstructured":"Jalan R, Bernardi M. Effective albumin concentration and cirrhosis mortality: from concept to reality. J Hepatol. 2013;59:918\u2013920.","journal-title":"J Hepatol"},{"key":"9665_CR5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/0148607191015004476","volume":"15","author":"JP Doweiko","year":"1991","unstructured":"Doweiko JP, Nompleggi DJ. The role of albumin in human physiology and pathophysiology, Part III: albumin and disease states. JPEN J Parenter Enteral Nutr. 1991;15:476\u2013483.","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"Suppl 4","key":"9665_CR6","first-page":"s18","volume":"11","author":"P Caraceni","year":"2013","unstructured":"Caraceni P, Tufoni M, Bonavita ME. Clinical use of albumin. Blood Transfus. 2013;11(Suppl 4):s18\u2013s25.","journal-title":"Blood Transfus"},{"key":"9665_CR7","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.26338","volume":"58","author":"R Garcia-Martinez","year":"2013","unstructured":"Garcia-Martinez R, Caraceni P, Bernardi M, Gines P, Arroyo V, Jalan R. Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology. 2013;58:1836\u20131846.","journal-title":"Hepatology"},{"issue":"Suppl 5","key":"9665_CR8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2036.16.s5.2.x","volume":"16","author":"TW Evans","year":"2002","unstructured":"Evans TW. Review article: albumin as a drug\u2013biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol Ther. 2002;16(Suppl 5):6\u201311.","journal-title":"Aliment Pharmacol Ther"},{"key":"9665_CR9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/bja\/85.4.599","volume":"85","author":"JP Nicholson","year":"2000","unstructured":"Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth. 2000;85:599\u2013610.","journal-title":"Br J Anaesth"},{"key":"9665_CR10","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1007\/s00894-014-2450-y","volume":"20","author":"TR Guizado","year":"2014","unstructured":"Guizado TR. Analysis of the structure and dynamics of human serum albumin. J Mol Model. 2014;20:2450.","journal-title":"J Mol Model"},{"key":"9665_CR11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/protein\/12.6.439","volume":"12","author":"S Sugio","year":"1999","unstructured":"Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K. Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng. 1999;12:439\u2013446.","journal-title":"Protein Eng"},{"key":"9665_CR12","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/15216540500404093","volume":"57","author":"M Fasano","year":"2005","unstructured":"Fasano M, Curry S, Terreno E, Galliano M, Fanali G, Narciso P, Notari S, et al. The extraordinary ligand binding properties of human serum albumin. IUBMB Life. 2005;57:787\u2013796.","journal-title":"IUBMB Life"},{"key":"9665_CR13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.mam.2011.12.002","volume":"33","author":"G Fanali","year":"2012","unstructured":"Fanali G, di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P. Human serum albumin: from bench to bedside. Mol Aspects Med. 2012;33:209\u2013290.","journal-title":"Mol Aspects Med"},{"key":"9665_CR14","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1248\/yakushi.14-00166","volume":"134","author":"M Anraku","year":"2014","unstructured":"Anraku M. Elucidation of the mechanism responsible for the oxidation of serum albumin and its application in treating oxidative stress-related diseases. Yakugaku zasshi. 2014;134:973\u2013979.","journal-title":"Yakugaku zasshi"},{"key":"9665_CR15","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/sj.bjp.0707251","volume":"151","author":"K Oettl","year":"2007","unstructured":"Oettl K, Stauber RE. Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol. 2007;151:580\u2013590.","journal-title":"Br J Pharmacol"},{"key":"9665_CR16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/358209a0","volume":"358","author":"XM He","year":"1992","unstructured":"He XM, Carter DC. Atomic structure and chemistry of human serum albumin. Nature. 1992;358:209\u2013215.","journal-title":"Nature"},{"key":"9665_CR17","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1248\/bpb.25.695","volume":"25","author":"U Kragh-Hansen","year":"2002","unstructured":"Kragh-Hansen U, Chuang VTG, Otagiri M. Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol Pharm Bull. 2002;25:695\u2013704.","journal-title":"Biol Pharm Bull"},{"key":"9665_CR18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2014.04.012","volume":"61","author":"V Arroyo","year":"2014","unstructured":"Arroyo V, Garcia-Martinez R, Salvatella X. Human serum albumin, systemic inflammation, and cirrhosis. J Hepatol. 2014;61:396\u2013407.","journal-title":"J Hepatol"},{"key":"9665_CR19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1042\/cs0950459","volume":"95","author":"GJ Quinlan","year":"1998","unstructured":"Quinlan GJ, Margarson MP, Mumby S, Evans TW, Gutteridge JM. Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion. Clin Sci (Lond). 1998;95:459\u2013465.","journal-title":"Clin Sci (Lond)"},{"key":"9665_CR20","doi-asserted-by":"crossref","first-page":"16712","DOI":"10.1016\/S0021-9258(19)89449-8","volume":"269","author":"J Neuzil","year":"1994","unstructured":"Neuzil J, Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem. 1994;269:16712\u201316719.","journal-title":"J Biol Chem"},{"key":"9665_CR21","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1164\/ajrccm.162.4.9910106","volume":"162","author":"AM Cantin","year":"2000","unstructured":"Cantin AM, Paquette B, Richter M, Larivee P. Albumin-mediated regulation of cellular glutathione and nuclear factor kappa B activation. Am J Respir Crit Care Med. 2000;162:1539\u20131546.","journal-title":"Am J Respir Crit Care Med"},{"key":"9665_CR22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.26021","volume":"57","author":"A Bortoluzzi","year":"2013","unstructured":"Bortoluzzi A, Ceolotto G, Gola E, Sticca A, Bova S, Morando F, Piano S, et al. Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms. Hepatology. 2013;57:266\u2013276.","journal-title":"Hepatology"},{"key":"9665_CR23","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1172\/JCI116364","volume":"91","author":"JF Keaney Jr","year":"1993","unstructured":"Keaney JF Jr, Simon DI, Stamler JS, Jaraki O, Scharfstein J, Vita JA, Loscalzo J. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J Clin Investig. 1993;91:1582\u20131589.","journal-title":"J Clin Investig"},{"key":"9665_CR24","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0272-6386(99)70306-9","volume":"33","author":"SB Kim","year":"1999","unstructured":"Kim SB, Chi HS, Park JS, Hong CD, Yang WS. Effect of increasing serum albumin on plasma D-dimer, von Willebrand factor, and platelet aggregation in CAPD patients. Am J Kidney Dis. 1999;33:312\u2013317.","journal-title":"Am J Kidney Dis"},{"key":"9665_CR25","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1478-3231.2006.01327.x","volume":"26","author":"H Jaeschke","year":"2006","unstructured":"Jaeschke H, Hasegawa T. Role of neutrophils in acute inflammatory liver injury. Liver Int. 2006;26:912\u2013919.","journal-title":"Liver Int"},{"key":"9665_CR26","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0008-6363(02)00492-3","volume":"55","author":"W-J Zhang","year":"2002","unstructured":"Zhang W-J, Frei B. Albumin selectively inhibits TNF alpha-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells. Cardiovasc Res. 2002;55:820\u2013829.","journal-title":"Cardiovasc Res"},{"key":"9665_CR27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/00365520902719273","volume":"44","author":"TA Chen","year":"2009","unstructured":"Chen TA, Tsao YC, Chen A, Lo GH, Lin CK, Yu HC, Cheng LC, et al. Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis. Scand J Gastroenterol. 2009;44:619\u2013625.","journal-title":"Scand J Gastroenterol"},{"key":"9665_CR28","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/hep.21737","volume":"46","author":"RP Mookerjee","year":"2007","unstructured":"Mookerjee RP, Stadlbauer V, Lidder S, Wright GAK, Hodges SJ, Davies NA, Jalan R. Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. Hepatology. 2007;46:831\u2013840.","journal-title":"Hepatology"},{"key":"9665_CR29","doi-asserted-by":"crossref","first-page":"G15","DOI":"10.1152\/ajpgi.90512.2008","volume":"296","author":"V Stadlbauer","year":"2009","unstructured":"Stadlbauer V, Mookerjee RP, Wright GAK, Davies NA, Jurgens G, Hallstrom S, Jalan R. Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol. 2009;296:G15\u2013G22.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"9665_CR30","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm.3516","volume":"20","author":"AJ O\u2019Brien","year":"2014","unstructured":"O\u2019Brien AJ, Fullerton JN, Massey KA, Auld G, Sewell G, James S, Newson J, et al. Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2. Nat Med. 2014;20:518\u2013523.","journal-title":"Nat Med"},{"key":"9665_CR31","doi-asserted-by":"crossref","first-page":"C439","DOI":"10.1152\/ajpcell.1993.265.2.C439","volume":"265","author":"R Qiao","year":"1993","unstructured":"Qiao R, Siflinger-Birnboim A, Lum H, Tiruppathi C, Malik AB. Albumin and Ricinus communis agglutinin decrease endothelial permeability via interactions with matrix. Am J Physiol. 1993;265:C439\u2013C446.","journal-title":"Am J Physiol"},{"key":"9665_CR32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00000542-200401000-00012","volume":"100","author":"JD Lang Jr","year":"2004","unstructured":"Lang JD Jr, Figueroa M, Chumley P, Aslan M, Hurt J, Tarpey MM, Alvarez B, et al. Albumin and hydroxyethyl starch modulate oxidative inflammatory injury to vascular endothelium. Anesthesiology. 2004;100:51\u201358.","journal-title":"Anesthesiology"},{"key":"9665_CR33","doi-asserted-by":"crossref","unstructured":"Garcia-Martinez R, Andreola F, Mehta G, Poulton K, Oria M, Jover M, Soeda J, et al. Immunomodulatory and antioxidant function of albumin stabilises the endothelium and improves survival in a rodent model of chronic liver failure. J Hepatol 2015;62:799-806.","DOI":"10.1016\/j.jhep.2014.10.031"},{"key":"9665_CR34","doi-asserted-by":"crossref","unstructured":"Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013;144:1426\u20131437.","DOI":"10.1053\/j.gastro.2013.02.042"},{"key":"9665_CR35","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbadis.2008.04.002","volume":"1782","author":"K Oettl","year":"2008","unstructured":"Oettl K, Stadlbauer V, Petter F, Greilberger J, Putz-Bankuti C, Hallstrom S, Lackner C, et al. Oxidative damage of albumin in advanced liver disease. Biochim Biophys Acta. 2008;1782:469\u2013473.","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl 2","key":"9665_CR36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1055\/s-2001-919056","volume":"39","author":"S Klammt","year":"2001","unstructured":"Klammt S, Brinkmann B, Mitzner S, Munzert E, Loock J, Stange J, Emmrich J, et al. Albumin binding capacity (ABiC) is reduced in commercially available human serum albumin preparations with stabilizers. Z Gastroenterol. 2001;39(Suppl 2):24\u201327.","journal-title":"Z Gastroenterol"},{"key":"9665_CR37","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1373\/49.4.581","volume":"49","author":"NV Bhagavan","year":"2003","unstructured":"Bhagavan NV, Lai EM, Rios PA, Yang J, Ortega-Lopez AM, Shinoda H, Honda SA, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem. 2003;49:581\u2013585.","journal-title":"Clin Chem"},{"key":"9665_CR38","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/lt.21504","volume":"14","author":"S Klammt","year":"2008","unstructured":"Klammt S, Mitzner SR, Stange J, Loock J, Heemann U, Emmrich J, Reisinger EC, et al. Improvement of impaired albumin binding capacity in acute-on-chronic liver failure by albumin dialysis. Liver Transplant. 2008;14:1333\u20139.","journal-title":"Liver Transplant"},{"key":"9665_CR39","doi-asserted-by":"crossref","unstructured":"Giannone FA, Domenicali M, Baldassarre M, Bartoletti M, Naldi M, Laggetta M, Bertucci C, et al. Ischaemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis. Liver Int 2015. doi: 10.1111\/liv.12860 .","DOI":"10.1111\/liv.12860"},{"key":"9665_CR40","doi-asserted-by":"crossref","unstructured":"Garcia-Martinez R, Noiret L, Sen S, Mookerjee R, Jalan R. Albumin infusion improves renal blood flow autoregulation in patients with acute decompensation of cirrhosis and acute kidney injury. Liver Int 2015;35:335\u2013343.","DOI":"10.1111\/liv.12528"},{"key":"9665_CR41","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.03.001","volume":"53","author":"European Association for the Study of the Liver","year":"2010","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53:397\u2013417.","journal-title":"J Hepatol"},{"key":"9665_CR42","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22853","volume":"49","author":"BA Runyon","year":"2009","unstructured":"Runyon BA, Committee APG. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49:2087\u20132107.","journal-title":"Hepatology"},{"key":"9665_CR43","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0168-8278(97)80081-5","volume":"27","author":"J Salo","year":"1997","unstructured":"Salo J, Gines A, Gines P, Piera C, Jimenez W, Guevara M, Fernandez-Esparrach G, et al. Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis. J Hepatol. 1997;27:645\u2013653.","journal-title":"J Hepatol"},{"key":"9665_CR44","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1053\/gast.1997.v113.pm9247479","volume":"113","author":"L Ruiz-del-Arbol","year":"1997","unstructured":"Ruiz-del-Arbol L, Monescillo A, Jimenez W, Garcia-Plaza A, Arroyo V, Rodes J. Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology. 1997;113:579\u2013586.","journal-title":"Gastroenterology"},{"key":"9665_CR45","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0168-8278(98)80288-2","volume":"28","author":"MC Vila","year":"1998","unstructured":"Vila MC, Sola R, Molina L, Andreu M, Coll S, Gana J, Marquez J, et al. Hemodynamic changes in patients developing effective hypovolemia after total paracentesis. J Hepatol. 1998;28:639\u2013645.","journal-title":"J Hepatol"},{"key":"9665_CR46","first-page":"295153","volume":"2013","author":"CS Kwok","year":"2013","unstructured":"Kwok CS, Krupa L, Mahtani A, Kaye D, Rushbrook SM, Phillips MG, Gelson W. Albumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: a systematic review and meta-analysis. BioMed Res Int. 2013;2013:295153.","journal-title":"BioMed Res Int"},{"key":"9665_CR47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2008-1040320","volume":"28","author":"P Gines","year":"2008","unstructured":"Gines P, Cardenas A. The management of ascites and hyponatremia in cirrhosis. Semin Liver Dis. 2008;28:43\u201358.","journal-title":"Semin Liver Dis"},{"key":"9665_CR48","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1478-3231.2010.02272.x","volume":"30","author":"F Salerno","year":"2010","unstructured":"Salerno F, Guevara M, Bernardi M, Moreau R, Wong F, Angeli P, Garcia-Tsao G, et al. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis. Liver Int. 2010;30:937\u2013947.","journal-title":"Liver Int"},{"key":"9665_CR49","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/hep.24786","volume":"55","author":"M Bernardi","year":"2012","unstructured":"Bernardi M, Caraceni P, Navickis RJ, Wilkes MM. Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology. 2012;55:1172\u20131181.","journal-title":"Hepatology"},{"key":"9665_CR50","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2010.02.023","volume":"53","author":"S Moller","year":"2010","unstructured":"Moller S, Henriksen JH. Cirrhotic cardiomyopathy. J Hepatol. 2010;53:179\u2013190.","journal-title":"J Hepatol"},{"key":"9665_CR51","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","volume":"36","author":"R Ortega","year":"2002","unstructured":"Ortega R, Gines P, Uriz J, Cardenas A, Calahorra B, De Las Heras D, Guevara M, et al. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology. 2002;36:941\u2013948.","journal-title":"Hepatology"},{"key":"9665_CR52","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s10620-007-9919-9","volume":"53","author":"S Neri","year":"2008","unstructured":"Neri S, Pulvirenti D, Malaguarnera M, Cosimo BM, Bertino G, Ignaccolo L, Siringo S, et al. Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome. Dig Dis Sci. 2008;53:830\u2013835.","journal-title":"Dig Dis Sci"},{"key":"9665_CR53","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","volume":"134","author":"M Martin-Llahi","year":"2008","unstructured":"Martin-Llahi M, Pepin MN, Guevara M, Diaz F, Torre A, Monescillo A, Soriano G, et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology. 2008;134:1352\u20131359.","journal-title":"Gastroenterology"},{"key":"9665_CR54","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","volume":"341","author":"P Sort","year":"1999","unstructured":"Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, Castells L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341:403\u2013409.","journal-title":"N Engl J Med"},{"key":"9665_CR55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cgh.2012.11.007","volume":"11","author":"F Salerno","year":"2013","unstructured":"Salerno F, Navickis RJ, Wilkes MM. Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials. Clin Gastroenterol Hepatol. 2013;11:123\u2013130.e121.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9665_CR56","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jhep.2004.05.009","volume":"41","author":"J Fernandez","year":"2004","unstructured":"Fernandez J, Navasa M, Garcia-Pagan JC, G-Abraldes J, Jimenez W, Bosch J, Arroyo V. Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis. J Hepatol. 2004;41:384\u2013390.","journal-title":"J Hepatol"},{"key":"9665_CR57","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.20829","volume":"42","author":"J Fernandez","year":"2005","unstructured":"Fernandez J, Monteagudo J, Bargallo X, Jimenez W, Bosch J, Arroyo V, Navasa M. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. Hepatology. 2005;42:627\u2013634.","journal-title":"Hepatology"},{"key":"9665_CR58","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/jhep.2002.30082","volume":"35","author":"J Fernandez","year":"2002","unstructured":"Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, Rodes J. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002;35:140\u2013148.","journal-title":"Hepatology"},{"key":"9665_CR59","doi-asserted-by":"crossref","unstructured":"Arvaniti V, D\u2019Amico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M, Burroughs AK. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 2010;139:1246\u20131256.","DOI":"10.1053\/j.gastro.2010.06.019"},{"key":"9665_CR60","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","volume":"60","author":"R Jalan","year":"2014","unstructured":"Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, Stadlbauer V, et al. Bacterial infections in cirrhosis: a position statement based on the EASL special conference 2013. J Hepatol. 2014;60:1310\u20131324.","journal-title":"J Hepatol"},{"key":"9665_CR61","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jhep.2012.06.013","volume":"57","author":"M Guevara","year":"2012","unstructured":"Guevara M, Terra C, Nazar A, Sola E, Fernandez J, Pavesi M, Arroyo V, et al. Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study. J Hepatol. 2012;57:759\u2013765.","journal-title":"J Hepatol"},{"key":"9665_CR62","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jhep.2014.11.017","volume":"62","author":"T Thevenot","year":"2015","unstructured":"Thevenot T, Bureau C, Oberti F, Anty R, Louvet A, Plessier A, Rudler M, et al. Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial. J Hepatol. 2015;62:822\u2013830.","journal-title":"J Hepatol"},{"key":"9665_CR63","first-page":"71","volume":"8","author":"K Tarao","year":"1983","unstructured":"Tarao K, Iwamura K. Influence of long-term administration of serum albumin on the prognosis of liver cirrhosis in man. Tokai J Exp Clin Med. 1983;8:71\u201378.","journal-title":"Tokai J Exp Clin Med"},{"key":"9665_CR64","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3748\/wjg.v12.i9.1403","volume":"12","author":"R-G Romanelli","year":"2006","unstructured":"Romanelli R-G, La Villa G, Barletta G, Vizzutti F, Lanini F, Arena U, Boddi V, et al. Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. World J Gastroenterol. 2006;12:1403\u20131407.","journal-title":"World J Gastroenterol"},{"key":"9665_CR65","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0168-8278(99)80194-9","volume":"30","author":"P Gentilini","year":"1999","unstructured":"Gentilini P, Casini-Raggi V, Di Fiore G, Romanelli RG, Buzzelli G, Pinzani M, La Villa G, et al. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. J Hepatol. 1999;30:639\u2013645.","journal-title":"J Hepatol"},{"key":"9665_CR66","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jhep.2014.09.005","volume":"62","author":"M Romero-Gomez","year":"2015","unstructured":"Romero-Gomez M, Montagnese S, Jalan R. Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. J Hepatol. 2015;62:437\u2013447.","journal-title":"J Hepatol"},{"key":"9665_CR67","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/CS20030357","volume":"106","author":"R Jalan","year":"2004","unstructured":"Jalan R, Kapoor D. Reversal of diuretic-induced hepatic encephalopathy with infusion of albumin but not colloid. Clin Sci. 2004;106:467\u2013474.","journal-title":"Clin Sci"},{"key":"9665_CR68","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jhep.2013.07.020","volume":"59","author":"M Simon-Talero","year":"2013","unstructured":"Simon-Talero M, Garcia-Martinez R, Torrens M, Augustin S, Gomez S, Pereira G, Guevara M, et al. Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study. J Hepatol. 2013;59:1184\u20131192.","journal-title":"J Hepatol"},{"key":"9665_CR69","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bpg.2012.01.002","volume":"26","author":"F Nevens","year":"2012","unstructured":"Nevens F, Laleman W. Artificial liver support devices as treatment option for liver failure. Best Pract Res Clin Gastroenterol. 2012;26:17\u201326.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"9665_CR70","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/jlts.2001.26922","volume":"7","author":"R Jalan","year":"2001","unstructured":"Jalan R, Williams R. Improvement in cerebral perfusion after MARS therapy: further clues about the pathogenesis of hepatic encephalopathy? Liver Transplant. 2001;7:713\u2013415.","journal-title":"Liver Transplant"},{"key":"9665_CR71","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.26185","volume":"57","author":"R Banares","year":"2013","unstructured":"Banares R, Nevens F, Larsen FS, Jalan R, Albillos A, Dollinger M, Saliba F, et al. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology. 2013;57:1153\u20131162.","journal-title":"Hepatology"},{"key":"9665_CR72","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/j.gastro.2011.12.056","volume":"142","author":"A Kribben","year":"2012","unstructured":"Kribben A, Gerken G, Haag S, Herget-Rosenthal S, Treichel U, Betz C, Sarrazin C, et al. Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology. 2012;142:782\u2013789.","journal-title":"Gastroenterology"},{"key":"9665_CR73","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1744-9987.2009.00762.x","volume":"13","author":"K Oettl","year":"2009","unstructured":"Oettl K, Stadlbauer V, Krisper P, Stauber RE. Effect of extracorporeal liver support by molecular adsorbents recirculating system and Prometheus on redox state of albumin in acute-on-chronic liver failure. Ther Apher Dial. 2009;13:431\u2013436.","journal-title":"Ther Apher Dial"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-015-9665-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-015-9665-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-015-9665-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T08:19:27Z","timestamp":1653207567000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-015-9665-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,29]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["9665"],"URL":"https:\/\/doi.org\/10.1007\/s12072-015-9665-6","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,29]]}}}